Markets:

Overview

News

Currencies

International

Treasuries

Exact Sciences Corporation - Common Stock (NQ:EXAS)

101.62 -0.12 (-0.12%)

Streaming Delayed Price Updated: 10:00 AM EST, Dec 16, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Exact Sciences Corporation - Common Stock

< Previous 1 2

...

15 16 17 18 19 20 21 22 Next >

This Cancer Screening Company Has A Better 5-Year Return Than Pfizer, Johnson & Johnson And Gilead ↗

September 06, 2021

Small-cap stocks have a history of outperforming large-cap names as they have the potential for rapid growth and have event-driven moves for share prices. A company focused...

Via Benzinga

3 Top Healthcare Stocks to Buy for August ↗

August 19, 2021

With excellent prospects, these three companies are built to last and today's prices are attractive.

Via The Motley Fool

Unusual Options Activity Insight: Exact Sciences ↗

August 13, 2021

Exact Sciences (NASDAQ:EXAS) shares experienced unusual o...

Via Benzinga

Unusual Options Activity Insight: Exact Sciences ↗

August 03, 2021

On Tuesday, shares of Exact Sciences (NASDAQ:EXAS) saw un...

Via Benzinga

Expert Ratings for Exact Sciences ↗

July 29, 2021

Within the last quarter, Exact Sciences (NASDAQ:EXAS) has observed the fol...

Via Benzinga

44 Stocks Moving In Thursday's Mid-Day Session ↗

July 29, 2021

Gainers NanoVibronix, Inc. (NASDAQ: NAOV) shares jumped 47.6% to $2.8198 after the company announced it received registration approval for UroShield from TGA Australia....

Via Benzinga

The Daily Biotech Pulse: Pfizer, Bristol-Myers Squibb Earnings, Amgen Goes Shopping, GlaxoSmithKline-Vir's COVID-19 Antibody Treatment Supply Deal ↗

July 28, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 27) Bio-Rad Laboratories, Inc...

Via Benzinga

The Daily Biotech Pulse: Merck's Disappointing Q2, Atreca Falls On Data, FDA Nod For Viatris, Nuvalent, Icosavax IPOs ↗

July 29, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 28) AbbVie Inc. (NYSE: ABBV)...

Via Benzinga

Why Exact Sciences Is Trading Higher Today ↗

May 20, 2021

Exact Sciences Corp (NASDAQ:EXAS) is trading higher Thursd...

Via Benzinga

28 Stocks Moving in Thursday's Pre-Market Session ↗

July 29, 2021

Gainers LendingClub Corporation (NYSE: LC) shares rose 44.6% to $23.49 in pre-market trading after the company reported better-than-expected Q2 results and raised guidance. Acer...

Via Benzinga

Exact Sciences (EXAS) Q2 2021 Earnings Call Transcript ↗

July 29, 2021

EXAS earnings call for the period ending June 30, 2021.

Via The Motley Fool

Topics Earnings

10 Stocks Moving In Wednesday's After-Hours Session ↗

July 28, 2021

Gainers Qualcomm (NASDAQ: QCOM) shares are trading higher after the company reported better-than-expected Q3 EPS and sales results and issued Q4 EPS guidance above estimates....

Via Benzinga

Why PAVmed Soared by 12% on Wednesday ↗

July 28, 2021

The company tapped a respected figure in its industry as a board vice chairman.

Via The Motley Fool

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

July 28, 2021

Gainers Corvus Pharmaceuticals (NASDAQ:CRVS

Via Benzinga

Exact Sciences: Q2 Earnings Insights ↗

July 28, 2021

Shares of Exact Sciences (NASDAQ:EXAS) moved lower in after-market trading after the company reported Q2 results. Quarterly Results Earnings per share were down 77.59% over the...

Via Benzinga

The Week Ahead In Biotech (July 25-31): Big Pharma Earnings, Iterum FDA Decision, Alzheimer's Conference, IPOs and More ↗

July 25, 2021

Biotech stocks rebounded in the week ended July 23, thanks to the broader market strength. The sector also benefitted from the optimism that was set in motion by the solid start...

Via Benzinga

Unusual Options Activity Insight: Exact Sciences ↗

July 14, 2021

Exact Sciences (NASDAQ:EXAS) shares experienced unusual options activity on Wednesday. The stock price moved down to $112.83 following the option alert. Sentiment: BULLISH...

Via Benzinga

10 Biggest Price Target Changes For Monday ↗

June 21, 2021

SVB Leerink raised Natera, Inc. (NASDAQ:NTRA) pr...

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For June 15, 2021 ↗

June 15, 2021

Upgrades According to Raymond James, the prior rating for Welltower Inc (NYSE:WELL) was changed from Market Perform to Strong Buy. For the first quarter, Welltower had an...

Via Benzinga

Cramer Gives His Opinion On Novavax, Exact Sciences And More ↗

June 08, 2021

On CNBC's "Mad Money Lightning Round," Jim Cramer said he prefers Moderna Inc (NASDAQ: MRNA) over Novavax, Inc. (NASDAQ: NVAX). Philip Morris International Inc. (...

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For June 3, 2021 ↗

June 03, 2021

Upgrades According to B of A Securities, the prior rating for Bloom Energy Corp (NYSE:BE) was changed from Underperform to Neutral. For the first quarter, Bloom Energy had...

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For May 25, 2021 ↗

May 25, 2021

Upgrades For Appian Corp (NASDAQ:APPN), Macquarie upgraded the previous rating of Underperform to Neutral. For the first quarter, Appian had an EPS of $0.06, compared to...

Via Benzinga

Why Exact Sciences Stock Soared Today ↗

May 20, 2021

The company's Cologuard DNA test appears to be in good shape to maintain its market leadership.

Via The Motley Fool

Guardant Had Colon Cancer Data, But Rival Exact Popped — Here's Why ↗

May 20, 2021

Guardant and Exact are in a "win-win situation," an analyst said Thursday as EXAS stock surged on a comparison to Guardant in colon cancer detection.

Via Investor's Business Daily

Cathie Wood Buys $26M Disney Shares And Sells $13M In Netflix: What You Need To Know ↗

May 16, 2021

Cathie Wood-led Ark Investment Management on Friday bought 150,556 shares, worth about $26.15 million, in Walt Disney Co (NYSE: DIS), marking its debut in the media and...

Via Benzinga

Exact Sciences' First-Quarter Results Show Its Strength Under Pressure ↗

May 15, 2021

Despite ongoing pandemic-related headwinds, the medical diagnostic test maker's revenue grew. So how will it perform as those headwinds dissipate?

Via The Motley Fool

Cathie Wood Sheds $33.6M Alibaba Shares On Earnings Day ↗

May 14, 2021

Cathie Wood-led Ark Investment Management on Thursday shed 162,840 shares, worth about $33.6 million, in Alibaba Group Holding (NYSE: BABA) after the company posted its first...

Via Benzinga

Why Exact Sciences Doesn't Have Much to Worry About With Declining COVID Testing ↗

May 13, 2021

The company has other more significant growth drivers.

Via The Motley Fool

3 Cathie Wood Stocks for a $150 Billion Market That's Just Forming ↗

May 13, 2021

Falling costs are ushering in a new era of screening for a dreaded disease.

Via The Motley Fool

Cathie Wood Piles Up Palantir For Third Day In A Row, Adding $39M Worth Of Shares ↗

May 12, 2021

Cathie Wood-led Ark Investment Management on Wednesday snapped up 2.07 million shares, worth about $39 million, in Palantir Technologies Inc (NYSE: PLTR), on a day the...

Via Benzinga

< Previous 1 2

...

15 16 17 18 19 20 21 22 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.